Skip to main content
Clinical Trials/NCT03836521
NCT03836521
Recruiting
Not Applicable

The International Multicenter Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry

Cedars-Sinai Medical Center1 site in 1 country2,000 target enrollmentAugust 15, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bicuspid Aortic Valve
Sponsor
Cedars-Sinai Medical Center
Enrollment
2000
Locations
1
Primary Endpoint
Death
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

The objective of this study is to evaluate the procedural and clinical outcomes of patients with bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.

Registry
clinicaltrials.gov
Start Date
August 15, 2016
End Date
August 15, 2028
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Raj Makkar

Profssor of Medicine, University of California

Cedars-Sinai Medical Center

Eligibility Criteria

Inclusion Criteria

  • Age≥18 years.
  • Severe aortic stenosis with bicuspid anatomy.
  • NYHA≥2 and/or syncope and/or angina.
  • Patient judged by the Heart Team as indicated for TAVR.

Exclusion Criteria

  • Age \<18 years
  • Asymptomatic patients
  • Pure aortic regurgitation.

Outcomes

Primary Outcomes

Death

Time Frame: 5 years

Death from any cause

Secondary Outcomes

  • Repeat hospitalization(5 years)
  • Acute kidney injury (stage 2 or 3)(5 years)
  • Mean aortic valve gradient by Doppler echocardiography(5 years)
  • Bleeding(5 years)
  • Vascular complication(5 years)
  • Prosthetic regurgitation by Doppler echocardiography(5 years)
  • Death from cardiac cause(5 years)
  • Stroke(5 years)

Study Sites (1)

Loading locations...

Similar Trials